🇮🇳

Index Intelligence

· daily

BSE FMCG Sector Regulatory Filings — October 16, 2026

Three filings from S&P BSE FMCG constituents were published on 16 October 2026: Radico Khaitan and Britannia each disclosed ESG ratings from NSE Sustainability Ratings and Analytics, and ITC announced a board meeting for 2 November 2026 to approve quarter and half-year results ended 30 September 2026. The filings contain no period-over-period financial figures, insider transactions, capital allocation actions, M&A terms, or forward guidance, so the enriched data available for this stream is limited to ESG rating outcomes and a scheduled results event. The most material development is Britannia's downward restatement of its FY 2024-25 ESG rating from 67 to 66 alongside a new FY 2025-26 rating of 67, with clarifications still pending; this reflects data-driven rating volatility rather than operational deterioration. Radico Khaitan's independently assigned score of 69 is the highest of the two disclosed ratings and was obtained without company engagement, which adds credibility to the rating. The ITC board meeting is the single dated catalyst in the stream and will be the first real source of period-over-period comparisons for the sector this cycle. Portfolio-level, the stream shows ESG scoring activity as the dominant disclosure theme for the day, and investors should treat the absence of quantitative data as a reason for caution rather than a signal of either strength or weakness.

3 medium 3 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 16, 2026

Four filings dated 15-16 October 2026 were reviewed for the India BSE PHARMA stream. Three of the four are routine, low-materiality disclosures: Apollo Hospitals' investor-meeting schedule, and two unsolicited ESG ratings (Max Healthcare at 66, Zydus Lifesciences at 71, the latter in the 'Leader' category). The only filing with governance relevance is Torrent Pharmaceuticals' resignation of Executive Director Amal Kelshikar, effective close of business on 16 October 2026, a cessation that carries a handover risk but no disclosed financial impact. The filings do not contain enriched period-over-period financials, forward guidance, insider transaction values, or capital allocation data, so no quantitative trend analysis across companies is possible from this set. The most actionable items are the Zydus ESG leadership signal, the Torrent senior management transition, and the upcoming Apollo investor meetings in November 2026. Investors should treat this digest as a disclosure-flow update rather than a fundamentals read.

4 medium 4 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 16, 2026

Across the 12 filings, the stream is dominated by two S&P BSE Realty constituents, DLF Limited and Oberoi Realty Limited, and the headline picture is strong booking and profit momentum alongside weak core revenue in DLF. Oberoi reported H1FY27 booking value of Rs 10,199.57 crore versus Rs 2,937.73 crore in H1FY26 and Q2FY27 PAT of Rs 759.01 crore, up about 39% sequentially, though Q2 consolidated revenue of Rs 1,670.95 lakh was down 6.1% YoY. DLF's Q2FY27 quarterly profit rose about 10% YoY to Rs 1,301.35 crore, but consolidated revenue from operations fell 23.3% YoY to Rs 1,260.58 crore and standalone revenue fell 32.1%, so earnings were carried by other income (including a Rs 738.71 crore CCD fair-value gain) and associate income rather than operations. Sentiment is positive on operating KPIs (sales bookings Rs 3,800 crore, net cash Rs 15,084 crore, DCCDL rental income up 9%) but DLF's auditors continue to flag CCI, IT SEZ and SEBI matters, which is the key unresolved overhang. Oberoi's capital return is steady with a Rs 2 per share interim dividend (record date October 23, payment from October 30, 2026), while governance items for both companies (auditor rotation at Oberoi, reclassification of Madhukar at DLF) are administrative with low materiality. The main market implication is that investors should separate DLF's operating trajectory from its non-operating earnings quality before the October 17 earnings call.

6 high priority 6 medium 12 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 16, 2026

Across the 15 filings for the S&P BSE IT stream (period 2026-10-16), the dominant theme is a split between solid top-line momentum and deteriorating earnings quality, with LTM Limited (formerly LTIMindtree) at the center of most of the disclosures. LTM's Q2 FY27 consolidated revenue of ₹118,076 million rose 13.6% YoY and 1.7% QoQ, yet PAT of ₹13,799 million was flat YoY (-0.1%) and down 6.0% QoQ as other income collapsed to ₹915 million from ₹3,004 million a year earlier, while free cash flow fell to ₹3,294 million from ₹9,218 million in Q1. Order inflow also weakened to $1.26 Bn (down ~25% QoQ and 21% YoY), and sub-contracting costs rose 41.2% YoY, signalling margin pressure and greater reliance on subcontractors. Wipro reported flat sequential IT services revenue ($2.61 Bn) with Q3 guidance of -1.5% to +0.5% constant-currency growth, with Americas 1 and Health both declining, though its 16.5% operating margin was up 50 bps QoQ. Persistent Systems' approval of up to ₹8,000 Crore NCDs and ₹1,000 Crore commercial paper to fund the Nagarro SE acquisition is the largest capital-structure event in the batch, and the remaining filings (TCS road show, HCL RSU grants, Wipro's FLARRE.AI stake, NIIT tax appeal, Tech Mahindra administrative notice) are routine or low-materiality.

6 high priority 9 medium 15 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 16, 2026

Across the 13 filings for the BSE SENSEX 30 stream dated 16 October 2026, the flow is dominated by routine disclosures: board meeting notices for Q2/H1 FY27 results (Bharat Electronics, ITC, Tata Steel, and the Larsen & Toubro call), investor meeting schedules (Bajaj Finance, TCS), and administrative items (HCL Technologies RSU grant, Tech Mahindra share certificate notice, Axis Bank director appointment). The most material developments are Power Grid's award of a Pune West 765kV BOOT transmission project (Annual Transmission Charges of Rs 199.55 crore, taking its FY27 TBCB haul to ten projects and Rs 7,863.63 crore), and Bajaj Finserv's September 2026 insurance data, which shows strong Bajaj Life new business growth (YTD new business premium up about 39.8%) but softening in individual non-single and group yearly renewable premiums. Period-over-period data is limited in the filings themselves, so the portfolio read is mainly on Bajaj Life's premium mix and the earnings calendar that sets up late October and early November. Insider-activity signals are largely absent, with the exception of a Tata Steel trading-window closure and the HCL RSU grant, which point to neutral management activity rather than conviction or concern. Overall the cluster reads as a quiet, event-calendar-driven session with one clear sector-level positive (transmission awards) and one mixed insurance print.

13 medium 13 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 15, 2026

Four BSE BANKEX constituent filings dated 15 October 2026 were reviewed, and all four are in scope (AU Small Finance Bank, Yes Bank twice, Axis Bank). The day's dominant development is Yes Bank's exchange clarification following a roughly 10% share price fall, tied to a Supreme Court judgment on 15 October 2026 concerning the Rs 8,415 crore AT-1 bond write-down of March 2020; the bank says it is still obtaining the final order and denies any Regulation 30 lapse. The other two filings are routine employee compensation and capital-raising items with no change to business fundamentals: AU Small Finance Bank's ESOP allotment of 4,03,913 shares (paid-up capital rising to Rs 751.77 crore) and Axis Bank's grant of 1,95,605 options at Rs 1,264.60 under its 2000-01 scheme. Period-over-period financial comparisons (YoY/QoQ values, margins, NIM, ROE) are not present in any of the four filings, so trend analysis at the portfolio level is limited to qualitative signals. The clearest sector theme is that legacy capital instrument and governance questions, not operating performance, are driving the day's risk narrative in private-sector banking. Forward-looking guidance, insider transactions beyond ESOP grants, and capital allocation data are also absent from the provided enriched fields, so conviction-based signals are not available.

2 high priority 2 medium 4 total filings
· daily

BSE Metal Sector Regulatory Filings — October 15, 2026

Five filings from the S&P BSE METAL constituent set are in scope for 15 October 2026: three from Jindal Steel and Jindal Stainless (Jindal Stainless appears twice across different filing types) and two from Tata Steel, which are the same NCLT-sanctioned amalgamation reported twice. The most material development is Jindal Paradip Port's Phase I commissioning (12.5 MTPA, certificate obtained 12 October, four days ahead of the 16 October contractual deadline), which adds port capacity where none existed before. The Tata Steel scheme is an internal group restructuring with no cash consideration and no disclosed P&L impact, though the Regional Director's objections on the antedated appointed date (1 April 2023) and the Section 19(1) holding question are procedural risks worth tracking. Jindal Stainless has a scheduled board meeting on 22 October to approve Q2/H1 FY27 results, with the trading window reopening 27 October. The filings contain no insider-trading, pledge, dividend, buyback, or quantified period-over-period financial data, so the quantitative trend analysis the stream normally supports is limited to Jindal Stainless' reported FY26 turnover of INR 42,955 crore and the emissions figures from its green mobility programme. Portfolio-level read: operational and governance news flow is constructive, with no evidence of margin or balance-sheet stress in these filings.

1 high priority 4 medium 5 total filings
· daily

BSE Auto Sector Regulatory Filings — October 15, 2026

This BSE AUTO stream covers two filings dated 15 October 2026: a Mahindra & Mahindra analyst/investor meeting notice for Q2 FY27 (neutral, materiality 2/10) and a Maruti Suzuki ITAT tax order (positive, materiality 6/10). Both companies are S&P BSE AUTO constituents, so both are in scope. The enriched period-over-period, insider, capital allocation, financial ratio and transaction fields were not populated for either filing, so no quantified YoY/QoQ trends, insider signals or valuation comparisons can be drawn; the analysis rests on the stated filing contents. The most material development is Maruti's favourable ITAT ruling, which implies a potential tax benefit of about Rs. 130,000 million including interest and a contingent liability reduction of about Rs. 63,000 million, with management stating no major impact on operations or reported financials. Mahindra's upcoming Q2 FY27 investor meeting on 5 November 2026 is the main scheduled catalyst for the sector. Market implications are limited to a sentiment and contingent-liability story for Maruti until the tax benefit is actually given effect through the Assessing Officer.

2 medium 2 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 15, 2026

Five filings from S&P BSE FMCG constituents cover a single reporting day (2026-10-15), but the substantive content is concentrated in Nestlé India, which accounts for three of the five filings and the bulk of the quantitative data. Nestlé India's Q2 FY27 standalone revenue from operations rose about 20.4% YoY to ₹67,883.4 Cr, and standalone profit for the period rose about 36.3% YoY to ₹10,267.7 Cr, with H1 profit of ₹20,018.9 Cr versus ₹14,124.3 Cr a year earlier. Growth is volume-led and broad-based, and cost of materials fell to 43.1% of sales from 45.5%, a margin tailwind that also reflects the low-cost-base dynamics investors should monitor against flagged food inflation and commodity pressures. Working-capital build in inventories and receivables and a ₹36.9 Cr exceptional charge are the less favourable offsets. The filings also disclose a 26% equity stake acquisition in Radiance KA Sunshine Seven Private Limited, a captive renewable energy developer, which is a capital allocation move focused on energy cost and sustainability rather than capacity. One filing carries an internal inconsistency: the PAT figure of ₹1,026.8 Cr in one press release does not reconcile with ₹10,267.7 Cr elsewhere and should be verified before relying on it. United Breweries and Marico contributed only scheduling notices with no quantitative results, so the portfolio-level read-through is limited to one company's strong print and the signalling value of the Q2 call calendar.

2 high priority 3 medium 5 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 15, 2026

Across the eight filings for the BSE Pharma stream dated 15 October 2026, the dominant theme is inorganic and strategic expansion led by Mankind Pharma, which approved up to EUR 45Mn of additional funding into its Netherlands subsidiary (aggregate EUR 50Mn) to acquire a 70% stake in CAR-T developer Armed Cell Therapeutics (ACTx) for approximately EUR 48Mn in instalments. The filings do not disclose period-over-period financial metrics, as the Netherlands vehicle was incorporated on 13 August 2026 with nil turnover and ACTx's financials are not disclosed, so no quantitative YoY or QoQ trend can be drawn from this batch. ESG signals were mixed: Mankind received an ESG rating of 71 for FY26 (positive), while Lupin's rating slipped one point to 70 from 71 on softer Social and Governance sub-scores (negative). Zydus Lifesciences advanced its Sri Lanka joint venture with a phased investment above USD 20Mn and commercial operations targeted for 2028, pointing to longer-dated capacity growth. Near-term attention centres on scheduled catalysts: Apollo Hospitals' Q2 FY27 results on 4 November 2026 followed by a call on 5 November, and Sun Pharma's Q2 results and earnings call on 30 October 2026. Given the procedural nature of several notices, the batch's investment content is concentrated in the Mankind-ACTx transaction and the upcoming earnings calendar.

1 high priority 7 medium 8 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 15, 2026

Across the five BSE Realty constituent filings dated 15 October 2026, the dominant theme is governance and reporting cadence rather than hard financial performance: three of five filings (Aditya Birla Real Estate, Brigade Enterprises twice) are board-meeting or trading-window notices for Q2/H1 FY27 results, with the Aditya Birla results board meeting on 26 October and Brigade's on 29 October 2026, followed by a Brigade analyst call on 30 October. No period-over-period financial figures were disclosed in these notices, so growth and margin trends cannot be quantified from this batch. The single material development is Prestige Estates' consummation of the first tranche of CPPIB's investment in Prestige Hospitality Ventures (INR 1,500 Crore: INR 950 Crore secondary sale of a 10% stake plus INR 550 Crore for Series A CCPS representing 5.79%), which is a positive capital-recycling event for the parent, with further tranches still pending. The Phoenix Mills intra-group amalgamation is a low-impact structural consolidation (transferor net worth only INR 3.70 Lakh; transferee turnover INR 10,639.14 Lakh) with no share issuance or change in shareholding pattern. Market-wide, the sector shows a pattern of closed trading windows and results-calendar clustering in late October, so near-term information flow will be concentrated in the next two weeks.

1 high priority 4 medium 5 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 15, 2026

Across the 25 filings for the India BSE IT stream (18 new, 7 contextual), the dominant theme is strong top-line momentum paired with margin and cash-conversion pressure. Tech Mahindra (Q2 FY27 revenue ₹16,180 Cr, up ~15-16% YoY, EBIT up 40.5%) and Persistent Systems (consolidated revenue ₹46,639 Cr, up 30.2% YoY) both grew headline revenue strongly, but Persistent's PAT fell 25.4% YoY as employee costs (+22.4%) and other expenses (+125.7%) outpaced revenue, and its Nagarro acquisition (100% at EUR 81/share, ~94.04% secured) is pressuring ROCE and cash conversion. Wipro showed the clearest demand-side warning: consolidated profit fell 1.9% YoY, total bookings dropped 22.9% QoQ in constant currency and large deal bookings fell 58.6% QoQ, though its completed ₹15,051 Cr buyback and standalone PAT growth of 9.5% offset some concern. Capital returns were prominent, led by Tech Mahindra's ₹15 interim dividend (record date 23 Oct 2026) and a 1:1 bonus recommendation, with the TCS BBY Services acquisition completed and the Oracle FS and KPIT board meetings (23 and 28 Oct) acting as near-term catalysts. Auditor emphasis-of-matter items on Tech Mahindra's ₹12,304 Mn Satyam claims remain a recurring governance watch point. Several filings are procedural with no figures, limiting quantitative comparison.

10 high priority 15 medium 25 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 15, 2026

Across the 18 filings for the BSE SENSEX 30 stream dated 15 October 2026, the dominant theme is Tech Mahindra's Q2 FY27 results cluster, which accounts for roughly half the filings and combines a strong headline print (consolidated revenue of Rs. 161,802 million, up 3.0% QoQ and about 15% YoY; PAT of Rs. 16,097 million, up 33.9% YoY) with a board-approved Rs. 15 interim dividend and a recommended 1:1 bonus issue. The quality of that beat is mixed: consolidated other income turned negative at Rs. (74) million versus Rs. 400 million a year earlier, free cash flow fell to $135 Mn from $237 Mn, and the Labour Codes impact of Rs. 2,724 million was booked as an exceptional item. Tata Consultancy Services and Tata Steel contributed structural and procedural news (an AI foundry launch with claimed 20-25% manufacturing productivity gains, completion of the BBY Services India LLP acquisition, and an NCLT-sanctioned internal amalgamation with no cash impact). Maruti Suzuki's ITAT ruling is the most material single-company tax item, with an estimated positive impact of about Rs. 130,000 million including interest. Several filings (Reliance, Mahindra & Mahindra, Axis Bank, Sun Pharma, NTPC) are administrative or event notices with no quantitative performance data, so the period-over-period picture rests almost entirely on Tech Mahindra and Maruti Suzuki. Notably, the Tech Mahindra filings are duplicative (multiple versions of the same board outcome), so their figures should not be double-counted.

7 high priority 11 medium 18 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 14, 2026

The digest covers nine filings, with seven from Canara Bank, one from Union Bank of India, and one from Axis Bank, all within the S&P BSE BANKEX constituent scope. Canara Bank dominates the filing flow and its Q2 FY27 results (quarter ended 30 September 2026) show a mixed but largely constructive picture: standalone net profit rose 8.40% YoY to ₹5,174.76 Cr, consolidated PAT after minority interest rose 11.0% YoY to ₹5,381.59 Cr, and half-year standalone PAT grew 5.3% to ₹10,030.58 Cr. Asset quality is the clearest positive, with gross NPA falling to 1.33% from 2.35% (down 102 bps YoY) and net NPA at 0.30%, while provisions for NPAs fell 11.0% YoY. Growth momentum on the balance sheet was strong, with global business up 15.88% YoY, advances up 19.46% and retail lending up 31.61%. Offsetting pressures were a 14.8% YoY decline in Treasury revenue, non-interest income down 18.2% YoY, and a 41.9% YoY drop in consolidated other income, which together explain why operating profit grew only 1.98% YoY despite the headline profit growth. Canara Bank's Bank of Baroda-style litigation overhang is limited to a Bombay High Court suit by a former figure that the bank says it has not yet been served with, and its pending Canbank Factors stake sale awaits regulatory approval. Union Bank of India and Axis Bank filings were procedural (an earnings call scheduled for 19 October 2026 and an ESOP allotment of 92,708 shares, respectively) with no financial data to assess performance.

3 high priority 6 medium 9 total filings
· daily

BSE Metal Sector Regulatory Filings — October 14, 2026

This was a very quiet session for the India BSE METAL stream, with only one filing from Lloyds Metals And Energy Limited dated 14 October 2026. The filing is a corporate governance disclosure rather than a financial results release, so no period-over-period performance comparisons, insider transactions, capital allocation changes, or quantified guidance are available for analysis. The core developments are the Board's approval of an enabling resolution to issue up to Rs. 3,000 Crore of Non-Convertible Debentures in private placement tranches, and approval to raise up to USD 130 million (with a USD 50 million upsize option) via Regulation S senior secured notes or other debt securities. The Board also cancelled a previously approved Rs. 600 Crore NCD issuance, while the separate Rs. 950 Crore NCD approval from 21 September 2026 remains intact. Collectively, this points to a significant expansion of the company's debt funding program, with potentially more than Rs. 4,500 Crore of new capacity under consideration. Market implications hinge on pricing, tenure, and use of proceeds, none of which are yet disclosed, so the filing is best treated as a financing-capacity signal to monitor rather than a directional earnings signal. No other BSE METAL constituent filings were available in this window.

1 high priority 1 total filings
· daily

BSE Auto Sector Regulatory Filings — October 14, 2026

Four filings were provided for the India BSE AUTO stream dated 2026-10-14, but only three are in scope: Hyundai Motor India (HMIL), Apollo Tyres, Balkrishna Industries and Samvardhana Motherson are all S&P BSE AUTO-linked automobile or auto-ancillary names, so all four are actually in scope. The dominant development is HMIL's Pune (Talegaon) plant inauguration, which lifts installed capacity from 170,000 to a planned 320,000 units by 2030 with up to INR 11,000 crore of investment and a combined HMIL footprint of roughly 1.14 million units with Chennai. The enriched period-over-period, insider, and forward-looking fields are largely absent from these filings: none disclose YoY or QoQ revenue, margin, or insider transaction figures, so quantitative trend synthesis is not possible from this set. The read-across is therefore qualitative: capacity expansion and export momentum at HMIL, routine compliance at Apollo and Balkrishna, and a minor, contested legal penalty at Motherson's US subsidiary. Materiality is low across the set (1 to 4 out of 10), and no filing provides guidance changes, buyback, dividend, or M&A terms to act on.

4 medium 4 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 14, 2026

Three BSE FMCG-constituent filings dated 14 October 2026 were reviewed, and all three are procedural or event-logistics disclosures rather than financial results. Nestle India published a newspaper notice on SEBI's special window for transfer and dematerialisation of physical shares, a shareholder-housekeeping item with materiality 2/10. United Breweries and Radico Khaitan each announced Q2 FY2026-27 earnings calls for 28 October 2026 at 3:00 p.m. IST, with Radico also committing to post its investor presentation on 27 October. No period-over-period financial values, forward guidance figures, insider transactions, capital allocation changes, or M&A terms are disclosed in these filings, so portfolio-level growth or margin trend analysis cannot be drawn from this batch. The actionable takeaway is the catalyst calendar: two alcohol-sector results events in the same week, which will be the first real data points for the sector in this cycle. Investors should treat the batch as a scheduling signal and wait for the 27-28 October results and transcripts before forming directional views.

3 medium 3 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 14, 2026

Three filings dated 14 October 2026 were reviewed for the India BSE PHARMA stream, covering Sun Pharmaceutical Industries, Dr. Reddy's Laboratories and Biocon. None of the filings contains quantitative period-over-period financial data, insider transactions, capital allocation actions or explicit numeric guidance, so the enriched fields are largely empty and cross-company trend analysis is not possible. The dominant developments are regulatory and commercial: Dr. Reddy's received a USFDA Form 483 with three observations after a Pre-Approval Inspection at its Visakhapatnam FTO-9 facility, a manufacturing-compliance item that bears directly on US launch timing, while Biocon secured a global settlement and licence with Genentech for its biosimilar Pebrilzo, with earliest licensed launches from Q1 CY2027 in the EU/UK and Q3 CY2028 in the US. Sun Pharma's filing is administrative, confirming a board meeting on 30 October 2026 to approve Q2/H1 FY27 results and a trading-window closure through 1 November 2026. The portfolio-level pattern is that regulatory-quality events and litigation resolution, rather than reported financials, are the actionable items this cycle, with the next hard catalyst being Sun Pharma's results on 30 October.

3 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 14, 2026

Two S&P BSE REALTY constituent filings were published on 2026-10-14, both procedural Regulation 30 intimations for upcoming earnings calls: DLF Limited (call on Saturday 17 October 2026 at 12:00 IST covering Q2/H1 FY2027 un-audited results) and Godrej Properties Limited (call on Friday 23 October 2026 at 17:00 IST covering Q2 FY2027). Neither filing discloses financial figures, period-over-period comparisons, forward-looking guidance, insider transactions, capital allocation actions, or M&A terms, so the enriched data fields that would normally support quantitative synthesis are empty for this cycle. Both filings carry neutral sentiment and low materiality (3/10 and 2/10), signalling that the real information content will arrive with the results themselves. The portfolio-level takeaway is that the sector's near-term catalyst path is concentrated in the second half of October, with both management teams positioned to address performance and outlook in the window. Investors should treat this stream as a calendar-setting update rather than a source of new fundamental evidence.

2 medium 2 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 14, 2026

Across the 13 filings for the S&P BSE IT stream dated October 14, 2026, the dominant theme is leadership transition and governance housekeeping at NIIT Limited, which replaced its CEO with Anish Sarkar effective October 14 and appointed two senior management persons, alongside director resignations at Oracle Financial Services Software. The most material operating datapoint is TCS's Q2FY27 print: revenue of ₹73,188 crore, up 0.5% QoQ and 2.8% YoY in constant currency, with stable 24% operating margin and 19% net margin, a $9.6 billion TCV, and annualized AI revenue above $3.1 billion (over 10% of revenue), offset by India revenue weakness from a project deferral and sequential declines in Consumer Business (-0.7% QoQ) and ERU (-0.5% QoQ). Earnings catalysts are clustered in the next two weeks: LTTS on October 19, Zensar's board meeting on October 28 and call on October 29, and LTM's investor meet on October 17. Mphasis faces a tax demand increase to ₹2,417.80 crore from ₹2,286.86 crore via a Section 154 rectification, which management says is not expected to be material. The filings contain little quantitative insurance on peer comparisons, so relative-performance judgments are limited to TCS's disclosed sequential trends.

1 high priority 12 medium 13 total filings